An approach for neuroprotective therapies of secondary brain damage after excitotoxic retinal injury in Mice

CNS Neuroscience and Therapeutics

Volumn 16, Issue 5, 2010, Pages

  Ito, Yasushi ^a   Shimazawa, Masamitsu ^a   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Lomerizine; Memantine; Mouse; N methyl D aspartate; Visual center

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; LOMERIZINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT;

BRAIN INJURY; CHEMICAL STRUCTURE; DRUG EFFECT; EYE DISEASE; GLAUCOMA; HUMAN; LATERAL GENICULATE NUCLEUS; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; RETINA DETACHMENT; RETINA GANGLION CELL; RETINA INJURY; RETINA ISCHEMIA; REVIEW; VISUAL DISORDER; VISUAL NERVOUS SYSTEM; ANIMAL; DISEASE MODEL; MOUSE; PATHOLOGY; RETINA DISEASE; SENSORY RECEPTOR; VISUAL FIELD;

ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEUROPROTECTIVE AGENTS; RETINAL DISEASES; SENSORY RECEPTOR CELLS; VISUAL FIELDS;

EID: 77956412172     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2010.00176.x     Document Type: Review

References (114)

1. Perry VH, Oehler R, Cowey A. Retinal ganglion cells that project to the dorsal lateral geniculate nucleus in the macaque monkey. Neuroscience 1984 12 : 1101 1123. (Pubitemid 14054295)
2. Perry VH, Cowey A. Retinal ganglion cells that project to the superior colliculus and pretectum in the macaque monkey. Neuroscience 1984 12 : 1125 1137. (Pubitemid 14054296)
3. Harris LR. The superior colliculus and movements of the head and eyes in cats. J Physiol 1980 300 : 367 391.
4. Kawasaki A, Kardon RH. Disorders of the pupil. Ophthalmol Clin North Am 2001 14 : 149 168.
5. Bonne C, Muller A, Villain M. Free radicals in retinal ischemia. Gen Pharmacol 1998 30 : 275 280. (Pubitemid 28046495)
6. Dreyer EB. A proposed role for excitotoxicity in glaucoma. J Glaucoma 1998 7 : 62 67.
7. Neufeld AH. Nitric oxide: A potential mediator of retinal ganglion cell damage in glaucoma. Surv Ophthalmol 1999 43 : S129 S135.
8. McKinnon SJ. Glaucoma, apoptosis, and neuroprotection. Curr Opin Ophthalmol 1997 8 : 28 37.
9. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989 107 : 453 464.
10. Gupta N, Ang LC, Noël de Tilly L, Bidaisee L, Yücel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006 90 : 674 678.
11. Gupta N, Greenberg G, de Tilly LN, Gray B, Polemidiotis M, Yücel YH. Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br J Ophthalmol 2009 93 : 56 60.
12. Drouyer E, Dkhissi-Benyahya O, Chiquet C, et al. Glaucoma alters the circadian timing system. PLoS One 2008 3 : e3931.
13. McKinnon SJ, Schlamp CL, Nickells RW. Mouse models of retinal ganglion cell death and glaucoma. Exp Eye Res 2009 88 : 816 824.
14. Nickells RW. Ganglion cell death in glaucoma: From mice to men. Vet Ophthalmol 2007 10 : 88 94.
15. Williams RW, Strom RC, Rice DS, Goldowitz D. Genetic and environmental control of variation in retinal ganglion cell number in mice. J Neurosci 1996 16 : 7193 7205.
16. Provencio I, Cooper HM, Foster RG. Retinal projections in mice with inherited retinal degeneration: Implications for circadian photoentrainment. J Comp Neurol 1998 395 : 417 439.
17. Hofbauer A, Drager UC. Depth segregation of retinal ganglion cells projecting to mouse superior colliculus. J Comp Neurol 1985 234 : 465 474.
18. Munoz DP, Guitton D. Fixation and orientation control by the tecto-reticulo-spinal system in the cat whose head is unrestrained. Rev Neurol 1989 145 : 567 579.
19. Levkovitch-Verbin H. Animal models of optic nerve diseases. Eye 2004 18 : 1066 1074.
20. Osborne NN, Wood JP, Chidlow G, Bae JH, Melena J, Nash MS. Ganglion cell death in glaucoma: What do we really know? Br J Ophthalmol 1999 83 : 980 986.
21. Koh JY, Choi DW. Selective blockade of non-NMDA receptors does not block rapidly triggered glutamate-induced neuronal death. Brain Res 1991 548 : 318 321.
22. Siliprandi R, Canella R, Carmignoto G, Schiavo N, Zanellato A, Zanoni R, Vantini G. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci 1992 8 : 567 573.
23. Joo CK, Choi JS, Ko HW, et al. Necrosis and apoptosis after retinal ischemia: Involvement of NMDA-mediated excitotoxicity and p53. Invest Ophthalmol Vis Sci 1999 40 : 713 720.
24. Lam TT, Abler AS, Kwong JM, Tso MO. N-methyl-D-aspartate (NMDA) - Induced apoptosis in rat retina. Invest Ophthalmol Vis Sci 1999 40 : 2391 2397.
25. Meldrum BS. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J Nutr 2000 130 : S1007 S1015.
26. Morizane C, Adachi K, Furutani I, et al. N(omega)-nitro-L-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo. Eur J Pharmacol 1997 328 : 45 49.
27. Vorwerk CK, Hyman BT, Miller JW, et al. The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity. Invest Ophthalmol Vis Sci 1997 38 : 2038 2044.
28. Hirooka K, Kourennyi DE, Barnes S. Calcium channel activation facilitated by nitric oxide in retinal ganglion cells. J Neurophysiol 2000 83 : 198 206.
29. Franco-Bourland RE, Guizar-Sahagun G, Garcia GA, et al. Retinal vulnerability to glutamate excitotoxicity in canine glaucoma: Induction of neuronal nitric oxide synthase in retinal ganglion cells. Proc Western Pharmacol Soc 1998 41 : 201 204.
30. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994 330 : 613 622.
31. Schuettauf F, Naskar R, Vorwerk CK, Zurakowski D, Dreyer EB. Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors. Invest Ophthalmol Vis Sci 2000 41 : 4313 4316.
32. Otori Y, Wei JY, Barnstable CJ. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci 1998 39 : 972 981.
33. Mosinger JL, Price MT, Bai HY, Xiao H, Wozniak DF, Olney JW. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol 1991 113 : 10 17.
34. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996 114 : 299 305.
35. Yoles E, Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch Ophthalmol 1998 116 : 906 910.
36. Yoneda S, Tanihara H, Kido N, Honda Y, Goto W, Hara H, Miyawaki N. Interleukin-1β mediates ischemic injury in the rat retina. Exp Eye Res 2001 73 : 661 667.
37. Sabel BA, Sautter J, Stoehr T, Siliprandi R. A behavioral model of excitotoxicity: Retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA administration in adult rats. Exp Brain Res 1995 106 : 93 105.
38. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 1996 37 : 1618 1624.
39. Manabe S, Lipton SA. Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest Ophthalmol Vis Sci 2003 44 : 385 392.
40. Akaike A, Maeda T, Kume T, Kaneko S. Bifemelane protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Jpn J Pharmacol 1998 76 : 313 316.
41. Shimazawa M, Inokuchi Y, Ito Y, et al. Involvement of ER stress in retinal cell death. Mol Vis 2007 13 : 578 587.
42. Suemori S, Shimazawa M, Kawase K, Satoh M, Nagase H, Yamamoto T, Hara H. Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. Invest Ophthalmol Vis Sci 2006 47 : 3975 3982.
43. Ito Y, Shimazawa M, Inokuchi Y, Fukumitsu H, Furukawa S, Araie M, Hara H. Degenerative alterations in the visual pathway after NMDA-induced retinal damage in mice. Brain Res 2008 1212 : 89 101.
44. Tanaka H, Ito Y, Nakamura S, Shimazawa M, Hara H. Involvement of brain-derived neurotrophic factor in time-dependent neurodegeneration in the murine superior colliculus after intravitreal injection of N-methyl-D-aspartate. Mol Vis 2009 15 : 662 669.
45. Jones EG, Tighilet B, Tran BV, Huntsman MM. Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus. J Comp Neurol 1998 397 : 371 393.
46. Salt TE. Mediation of thalamic sensory input by both NMDA receptors and non-NMDA receptors. Nature 1986 322 : 263 265.
47. Salt TE. Excitatory amino acid receptors and synaptic transmission in the rat ventrobasal thalamus. J Physiol 1987 391 : 499 510.
48. Scharfman HE, Lu SM, Guido W, Adams PR, Sherman SM. N-methyl-D-aspartate receptors contribute to excitatory postsynaptic potentials of cat lateral geniculate neurons recorded in thalamic slices. Proc Natl Acad Sci USA 1990 87 : 4548 4552.
49. Fellin T, Carmignoto G. Neurone-to-astrocyte signalling in the brain represents a distinct multifunctional unit. J Physiol 2004 559 : 3 15.
50. Rossi DJ, Brady JD, Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 2007 10 : 1377 1386.
51. Uehara T, Nakamura T, Yao D, et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006 441 : 513 517.
52. Wang X, Sam-Wah Tay S, Ng YK. Nitric oxide, microglial activities and neuronal cell death in the lateral geniculate nucleus of glaucomatous rats. Brain Res 2000 878 : 136 147.
53. Nucci C, Morrone L, Rombolà L, Nisticò R, Piccirilli S, Cerulli L. Multifaceted roles of nitric oxide in the lateral geniculate nucleus: From visual signal transduction to neuronal apoptosis. Toxicol Lett 2003 139 : 163 173.
54. Vrabec JP, Levin LA. The neurobiology of cell death in glaucoma. Eye 2007 21 : S11 S14.
55. Finn JT, Weil M, Archer F, Siman R, Srinivasan A, Raff MC. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci 2000 20 : 1333 1341.
56. Lund RD. Synaptic patterns of the superficial layers of the superior colliculus of the rat. J Comp Neurol 1969 135 : 179 208.
57. Lund JS, Remington FL, Lund RD. Differential central distribution of optic nerve components in the rat. Brain Res 1976 116 : 83 100.
58. Boyes WK, Veronesi B. Electrophysiological and morphological evidence for a diameter-based innervation pattern of the superior colliculus. Exp Neurol 1988 101 : 190 207.
59. Koyama Y. Functional alterations of astroglia on brain pathologies and their intracellular mechanisms. Folia Pharmacol Jpn 2002 119 : 135 143.
60. Weibel D, Kreutzberg GW, Schwab ME. Brain-derived neurotrophic factor (BDNF) prevents lesion-induced axonal die-back in young rat optic nerve. Brain Res 1995 679 : 249 254.
61. Ikeda K, Tanihara H, Honda Y, Tatsuno T, Noguchi H, Nakayama C. BDNF attenuates retinal cell death caused by chemically induced hypoxia in rats. Invest Ophthalmol Vis Sci 1999 40 : 2130 2140.
62. Ota T, Hara H, Miyawaki N. Brain-derived neurotrophic factor inhibits changes in soma-size of retinal ganglion cells following optic nerve axotomy in rats. J Ocul Pharmacol Ther 2002 18 : 241 249.
63. Sawai H, Clarke DB, Kittlerova P, Bray GM, Aguayo AJ. Brain-derived neurotrophic factor and neurotrophin-4/5 stimulate growth of axonal branches from regenerating retinal ganglion cells. J Neurosci 1996 16 : 3887 3894.
64. Agarwala S, Kalil RE. Axotomy-induced neuronal death and reactive astrogliosis in the lateral geniculate nucleus following a lesion of the visual cortex in the rat. J Comp Neurol 1998 392 : 252 263.
65. Hetman M, Kanning K, Cavanaugh JE, Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 1999 274 : 22569 22580.
66. Nakazawa T, Tamai M, Mori N. Brain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathways. Invest Ophthalmol Vis Sci 2002 43 : 3319 3326.
67. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006 361 : 1545 1564.
68. Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 2002 67 : 203 233.
69. Parsons CG, Danysz W, Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacol 1999 38 : 735 767.
70. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003 348 : 1333 1341.
71. Hare WA, WoldeMussie E, Weinreb RN, et al. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey. II: Structural measures. Invest Ophthalmol Vis Sci 2004 45 : 2640 2651.
72. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996 80 : 389 393.
73. Yücel YH, Gupta N, Zhang Q, Mizisin AP, Kalichman MW, Weinreb RN. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol 2006 124 : 217 225.
74. Kornhuber J, Quack G. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. Neurosci Lett 1995 195 : 137 139.
75. Zajaczkowski W, Quack G, Danysz W. Infusion of (+)-MK-801 and memantine-contrasting effects on radial maze learning in rats with entorhinal cortex lesion. Eur J Pharmacol 1996 296 : 239 246.
76. Minkeviciene R, Banerjee P, Tanila H. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther 2004 311 : 677 682.
77. Harada T, Harada C, Nakamura K, et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 2007 117 : 1763 1770.
78. Grunert U, Haverkamp S, Fletcher EL, Wassle H. Synaptic distribution of ionotropic glutamate receptors in the inner plexiform layer of the primate retina. J Comp Neurol 2002 447 : 138 151.
79. Nakazawa T, Shimura M, Endo S, Takahashi H, Mori N, Tamai M. N-Methyl-D-aspartic acid suppresses Akt activity through protein phosphatase in retinal ganglion cells. Mol Vis 2005 11 : 1173 1182.
80. Ito Y, Nakamura S, Tanaka H, Shimazawa M, Araie M, Hara H. Memantine protects against secondary neuronal degeneration in lateral geniculate nucleus and superior colliculus after retinal damage in mice. CNS Neurosci Ther 2008 14 : 192 202.
81. Jaubert-Miazza L, Green E, Lo FS, Bui K, Mills J, Guido W. Structural and functional composition of the developing retinogeniculate pathway in the mouse. Vis Neurosci 2005 22 : 661 676.
82. Marvanova M, Lakso M, Pirhonen J, Nawa H, Wong G, Castren E. The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 2001 18 : 247 258.
83. Meisner F, Scheller C, Kneitz S, et al. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: A novel pharmacological action of memantine. Neuropsychopharmacology 2008 33 : 2228 2236.
84. Yücel YH, Yeung J, Weinreb RN, Kaufman PL, Gupta N. Alteration of nerve growth factor receptors TrkB and TrkC in the lateral geniculate nucleus. Paper presented at Annual Association for Research in Vision and Ophthalmology Meeting, May 4, Fort Lauderdale, FL, 2002.
85. Hara H, Morita T, Sukamoto T, Cutrer FM. Lomerizine (KB-2796), a new antimigraine drug. CNS Drug Rev 1995 1 : 204 226.
86. 2+ channel blocker as an anti-glaucoma drug: Effects on ocular circulation and retinal neuronal damage. Cardiovasc Drug Rev 2004 22 : 199 214.
87. Kanazawa T, Nakasu Y, Masuda M, Handa J. Acute effect of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl)-piperazine dihydrochloride, KB-2796, on the cerebral blood flow in unanesthetized cats. Arch Jpn Chir 1986 55 : 682 688.
88. Martinez A, Sanchez M. Ocular blood flow and glaucoma. Br J Ophthalmol 2008 1301 : 1301 1302.
89. Flammer J, Orgül S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res 1998 B : 267 289.
90. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002 21 : 359 393.
91. 2+ antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989 227 : 408 412.
92. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 1993 115 : 608 613. (Pubitemid 23137645)
93. Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology 1996 103 : 283 288.
94. Karim Z, Sawada A, Kawakami H, Yamamoto T, Taniguchi T. A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat. Curr Eye Res 2006 31 : 273 283.
95. Takahashi K, Lam TT, Edward DP, Buchi ER, Tso MO. Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol 1992 110 : 862 870.
96. 2+ channel blockers on directional selectivity of rabbit retinal ganglion cells. J Neurophysiol 1995 74 : 12 23.
97. Adachi K, Kashii S, Masai H, et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol 1998 236 : 766 774.
98. Gaspar AZ, Flammer J, Hendrickson P. Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases. Eur J Ophthalmol 1994 4 : 24 28.
99. Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma 1999 8 : 117 123.
100. 2+ channel blocker, on the microcirculation in the optic nerve head in conscious rabbits: A study using a laser speckle technique. Exp Eye Res 1999 69 : 185 193.
101. 2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res 2000 70 : 475 484.
102. 2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice. CNS Neurosci Ther 2009. Epub ahead of print.
103. 2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures. Jpn J Pharmacol 1993 61 : 361 365.
104. Hara H, Ozaki A, Yoshidomi M, Sukamoto T. Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia. Arch Int Pharmacodyn Ther 1990 304 : 206 218.
105. Yamada H, Chen YN, Aihara M, Araie M. Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia. Brain Res 2006 1071 : 75 80.
106. Kawashima T, Awata N, Satomi O, et al. Absorption, distribution and excretion of 1-[Bis(4-fluorophenyl)methyl]-4 (2, 3, 4-trimethoxybenzyl) piperazine dihydrochloride (KB-2796) after single oral administration in rats. Drug Metab Pharmacokinet 1990 5 : 723 737.
107. Yamashita A, Ozaki A, Ikegami A, Hayashi A, Hara H, Sukamoto T, Ito K. Effects of a new diphenylpiperazine calcium antagonist, KB-2796, on cerebral ischemic neuronal damage in rats. Gen Pharmacol 1993 24 : 1473 1480.
108. Minckler DS, Bunt AH, Johanson GW. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 1977 16 : 426 441.
109. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma, II: The site of injury and susceptibility to damage. Arch Ophthalmol 1981 99 : 635 649.
110. Zhang L, Ino-ue M, Dong K, Yamamoto M. Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. Curr Eye Res 2000 20 : 131 136.
111. Chan SY, Ochs S, Worth RM. The requirement for calcium ions and the effect of other ions on axoplasmic transport in mammalian nerve. J Physiol 1980 301 : 477 504.
112. Johansson JO. Influence of low IOP and low calcium on retrograde axoplasmic transport in rat optic nerve in vitro. Exp Eye Res 1985 41 : 739 744.
113. Taft WC, Clifton GL, Blair RE, DeLorenzo RJ. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res 1989 483 : 143 148.
114. Lees GJ. Inhibition of the retrograde axonal transport dopamine-beta-hydroxylase antibodies by the calcium ionophore A23187. Brain Res 1985 345 : 62 67.